Haemodynamic Effects of Anaemia in Patients with Acute Decompensated Heart Failure

Table 1

Basic characteristics of the study group.

	Study group n = 97
Age (years)	71.5 ± 12.6
Men	77 (79.4)
NYHA class: III/IV	62 (63.9)/35 (36.1)
Atrial fibrillation	61 (62.9)
Arterial hypertension	64 (66.0)
Chronic obstructive pulmonary disease	15 (15.5)
Chronic kidney disease	28 (28.9)
Diabetes mellitus	48 (49.5)
Creatinine (mg/dl)	1.31 ± 0.51
eGFR (ml/min/1.72 m^2)	62.2 ± 23.6
Urea (mg/dl)	54.2 ± 26.6
hsTnT (ng/L)	106.9 ± 263.6
NT-proBNP (pg/ml)	6214 ± 7196
Haemoglobin (g/dl)	12.6 ± 2.3
LVEF (%)	37.3 ± 14.1
LVEF category: <40%/40–49%/≥50%	59 (60.8)/12 (12.4)/26 (26.8)
Pharmacotherapy at admission
Beta-blockers	74 (76.3)
Angiotensin-converting-enzyme inhibitors/angiotensin receptor blockers	58 (59.8)/10 (10.3)
Mineralocorticoid receptor antagonist	31 (32.0)
Diuretic	69 (71.1)

Data are presented as mean ± SD or n (%). eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; NT-proBNP, N-terminal probrain natriuretic peptide; hsTnT, high-sensitivity troponin T.